Ubiquitin Proteasome-dependent Degradation of the Transcriptional Coactivator PGC-1{alpha} Via the N-terminal Pathway

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Aug 18

PMID 20713359

Citations 46

Authors

Julie Trausch-Azar

Teresa C Leone

Daniel P Kelly

Alan L Schwartz

Affiliations

Soon will be listed here.

Abstract

PGC-1α is a potent, inducible transcriptional coactivator that exerts control on mitochondrial biogenesis and multiple cellular energy metabolic pathways. PGC-1α levels are controlled in a highly dynamic manner reflecting regulation at both transcriptional and post-transcriptional levels. Here, we demonstrate that PGC-1α is rapidly degraded in the nucleus (t(½ 0.3 h) via the ubiquitin proteasome system. An N-terminal deletion mutant of 182 residues, PGC182, as well as a lysine-less mutant form, are nuclear and rapidly degraded (t(½) 0.5 h), consistent with degradation via the N terminus-dependent ubiquitin subpathway. Both PGC-1α and PGC182 degradation rates are increased in cells under low serum conditions. However, a naturally occurring N-terminal splice variant of 270 residues, NT-PGC-1α is cytoplasmic and stable (t(½>7 h), providing additional evidence that PGC-1α is degraded in the nucleus. These results strongly suggest that the nuclear N terminus-dependent ubiquitin proteasome pathway governs PGC-1α cellular degradation. In contrast, the cellular localization of NT-PCG-1α results in a longer-half-life and possible distinct temporal and potentially biological actions.

Citing Articles

Non-catalytic mechanisms of KMT5C regulating hepatic gluconeogenesis.

Zhao Q, Cui X, Zhu Q, Li F, Bao R, Shi T Nat Commun. 2025; 16(1):1483.

PMID: 39929827 PMC: 11811016. DOI: 10.1038/s41467-025-56696-y.

-Synuclein ubiquitination - functions in proteostasis and development of Lewy bodies.

Ho H, Wing S Front Mol Neurosci. 2024; 17:1498459.

PMID: 39600913 PMC: 11588729. DOI: 10.3389/fnmol.2024.1498459.

Commercially available PGC-1α antibodies vary greatly in specificity and sensitivity.

Galipeau M, Schmitt C, Baldwin C, Gunes A, Estall J MicroPubl Biol. 2024; 2024.

PMID: 39247789 PMC: 11380096. DOI: 10.17912/micropub.biology.001268.

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases.

Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y Signal Transduct Target Ther. 2024; 9(1):50.

PMID: 38424050 PMC: 10904817. DOI: 10.1038/s41392-024-01756-w.

Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α.

Liu B, Xie D, Huang X, Jin S, Dai Y, Sun X Diabetologia. 2024; 67(4):724-737.

PMID: 38216792 PMC: 10904493. DOI: 10.1007/s00125-023-06073-5.

References

Lin J, Handschin C, Spiegelman B . Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005; 1(6):361-70. DOI: 10.1016/j.cmet.2005.05.004. View

LEHMAN J, Barger P, Kovacs A, Saffitz J, Medeiros D, Kelly D . Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000; 106(7):847-56. PMC: 517815. DOI: 10.1172/JCI10268. View

Handschin C, Spiegelman B . Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006; 27(7):728-35. DOI: 10.1210/er.2006-0037. View

Trausch-Azar J, Lingbeck J, Ciechanover A, Schwartz A . Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD. J Biol Chem. 2004; 279(31):32614-9. DOI: 10.1074/jbc.M403794200. View

Dominy Jr J, Lee Y, Gerhart-Hines Z, Puigserver P . Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5. Biochim Biophys Acta. 2009; 1804(8):1676-83. PMC: 2886158. DOI: 10.1016/j.bbapap.2009.11.023. View

Ravid T, Hochstrasser M . Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nat Cell Biol. 2007; 9(4):422-7. DOI: 10.1038/ncb1558. View

Kuo M, den Besten W, Bertwistle D, Roussel M, Sherr C . N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 2004; 18(15):1862-74. PMC: 517406. DOI: 10.1101/gad.1213904. View

Arany Z, Foo S, Ma Y, Ruas J, Bommi-Reddy A, Girnun G . HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008; 451(7181):1008-12. DOI: 10.1038/nature06613. View

Lingbeck J, Trausch-Azar J, Ciechanover A, Schwartz A . E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1. Oncogene. 2005; 24(42):6376-84. DOI: 10.1038/sj.onc.1208789. View

10.

Coulombe P, Rodier G, Bonneil E, Thibault P, Meloche S . N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol. 2004; 24(14):6140-50. PMC: 434260. DOI: 10.1128/MCB.24.14.6140-6150.2004. View

11.

Kelly D, Scarpulla R . Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004; 18(4):357-68. DOI: 10.1101/gad.1177604. View

12.

Esterbauer H, Oberkofler H, Krempler F, Patsch W . Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics. 1999; 62(1):98-102. DOI: 10.1006/geno.1999.5977. View

13.

Sun L, Trausch-Azar J, Muglia L, Schwartz A . Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism. Proc Natl Acad Sci U S A. 2008; 105(9):3339-44. PMC: 2265166. DOI: 10.1073/pnas.0800165105. View

14.

Ciechanover A, Ben-Saadon R . N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 2004; 14(3):103-6. DOI: 10.1016/j.tcb.2004.01.004. View

15.

Fajerman I, Schwartz A, Ciechanover A . Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochem Biophys Res Commun. 2004; 314(2):505-12. DOI: 10.1016/j.bbrc.2003.12.116. View

16.

Vosper J, McDowell G, Hindley C, Fiore-Heriche C, Kucerova R, Horan I . Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis. J Biol Chem. 2009; 284(23):15458-68. PMC: 2708843. DOI: 10.1074/jbc.M809366200. View

17.

Cadwell K, Coscoy L . Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science. 2005; 309(5731):127-30. DOI: 10.1126/science.1110340. View

18.

Puigserver P, Wu Z, Park C, Graves R, Wright M, Spiegelman B . A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998; 92(6):829-39. DOI: 10.1016/s0092-8674(00)81410-5. View

19.

Sun L, Trausch-Azar J, Ciechanover A, Schwartz A . Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation. J Biol Chem. 2005; 280(28):26448-56. DOI: 10.1074/jbc.M500373200. View

20.

Doolman R, Leichner G, Avner R, Roitelman J . Ubiquitin is conjugated by membrane ubiquitin ligase to three sites, including the N terminus, in transmembrane region of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for sterol-regulated enzyme degradation. J Biol Chem. 2004; 279(37):38184-93. DOI: 10.1074/jbc.M405935200. View